These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6724258)

  • 1. Dissolution of human cholesterol gallstones in stimulated chenodeoxycholate-rich and ursodeoxycholate-rich biles. An in vitro study of dissolution rates and mechanisms.
    Park YH; Igimi H; Carey MC
    Gastroenterology; 1984 Jul; 87(1):150-8. PubMed ID: 6724258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms.
    Salvioli G; Igimi H; Carey MC
    J Lipid Res; 1983 Jun; 24(6):701-20. PubMed ID: 6886562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates.
    Igimi H; Carey MC
    J Lipid Res; 1981 Feb; 22(2):254-70. PubMed ID: 7240957
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 6. Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates.
    Carey MC; Montet JC; Phillips MC; Armstrong MJ; Mazer NA
    Biochemistry; 1981 Jun; 20(12):3637-48. PubMed ID: 7260061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissolution of human cholesterol gallstones in vitro with bile salts. A scanning and stereoscanning electron microscopic study.
    Funatsu K; Phillips MJ
    Lab Invest; 1979 Feb; 40(2):166-71. PubMed ID: 431035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.
    Igimi H; Asakawa S; Watanabe D; Shimura H
    Gastroenterol Jpn; 1983 Apr; 18(2):93-7. PubMed ID: 6852442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current problem of chemical gallstone dissolution.
    Leuschner U
    Tokai J Exp Clin Med; 1983 May; 8(2):117-27. PubMed ID: 6419403
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical perspective on the treatment of gallstones with ursodeoxycholic acid.
    Salen G
    J Clin Gastroenterol; 1988; 10 Suppl 2():S12-7. PubMed ID: 3062079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile salt-membrane interactions and the physico-chemical mechanisms of bile salt toxicity.
    Heuman DM
    Ital J Gastroenterol; 1995 Sep; 27(7):372-5. PubMed ID: 8563009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile salt hydrophobicity controls vesicle secretion rates and transformations in native bile.
    Cohen DE; Leighton LS; Carey MC
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G386-95. PubMed ID: 1415551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.
    Bazzoli F; Fromm H; Sarva RP; Sembrat RF; Ceryak S
    Gastroenterology; 1982 Oct; 83(4):753-60. PubMed ID: 7106506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 17. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone.
    Kanazawa Y; Koizumi M; Hirakawa H; Endo K; Yoshida S; Miyakawa T; Konno Y; Goto Y; Goto J; Nambara T
    Tohoku J Exp Med; 1982 Mar; 136(3):235-49. PubMed ID: 7071843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of human lymphocyte function by bile salts.
    Keane RM; Gadacz TR; Munster AM; Birmingham W; Winchurch RA
    Surgery; 1984 Apr; 95(4):439-43. PubMed ID: 6710340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver.
    Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N
    Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.